Content Laboratory founder &
author of The Reputation Bank
Marylou McNally is president and founder Content Laboratory that works with health care and life sciences companies on branding, corporate communications, issues management, marketing, product and organizational communications, content creation, culture development, change management, reputation, and investor relations. Currently, Marylou is advisor to the CEO and leader of communications strategy and implementation for Akari Therapeutics, a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. Prior to Akari, Marylou advised the CEO of Enzyvant (now part of Sumitomo Pharma America, Inc.) on company strategy, communications on the development pathway to FDA approval of one of the first Regenerative Medicine Advanced Therapies, and strategies for company brand, product brand, market access, stakeholder management, CMC, culture, thought leadership, and product communications. At Alexion (now AstraZeneca Rare Disease) she provided consultation, strategic and execution leadership for the Complement Franchise, C-Suite, Culture team, and Human Resources. She created the brand strategy and led the global company brand development, strategy activation and culture brand implementation for Baxalta, a $6B biopharmaceutical company (now Takeda). Marylou is also author of the communications and reputation planning tool, The Reputation Bank.
Prior to forming Content Laboratory, Marylou served as VP Global Communications and brand lead for Hill-Rom (now part of Baxter), a $2.5B medical technology company. She was head of external communications for the U.S. pharmaceutical division of Abbott (now AbbVie) where she managed numerous issues, created education campaigns that enhanced the company’s reputation and led product programs that delivered market expansion and share for HIV, cardiovascular and immunology franchise.
As executive vice president of the mid-size independent health care marketing and public relations agency, Dorland Global, Marylou led teams for clients such as P&G. For P&G, she led the launch of an innovative water filtration brand extension achieving major national media coverage and creating global attention for their responsibility program that provided for children’s safe drinking water in vulnerable regions around the world. For Actonel, the P&G/Sanofi co-promoted osteoporosis drug, she led the creative development and launch of an integrated national bone health education program that contributed to a significant increase in share and market.
At the beginning of her career, she led brand positioning, strategic planning, marketing, research, physician integration and image development for a large, regional integrated health care system, generating double-digit increases in consumer brand loyalty and preference in a crowded marketplace.
Marylou McNally received her Bachelor of Arts degree in Communications from Temple University.